We care about creating quality biologics with passion

Innovative development and manufacturing solutions to get safe and effective biotherapeutics to patients.

We create quality biologics through a passion to get safe and effective biotherapeutics to patients.

Development & manufacturing solutions

Our innovative solutions and dedicated scientists come together to provide industry leading capabilities to take your project from idea to global supply. We don’t just provide the capabilities we also provide extensive regulatory, IP and clinical support. We are committed to positive outcomes and delivering projects on time to specification.

Our values

These are the values that we at Polpharma Biologics are guided by, help shape our decisions and drive us forward. We care about:

Creating quality biologics with passion

We are passionate about providing safe and effective medicines to patients.

Delivering on our commitments

We are committed to positive outcomes and delivering projects on time, to specification.

Being respectful and transparent

We are open and honest without exception.

Our sites

With state-of-the-art facilities across Europe, Polpharma Biologics is at the forefront of the next wave in biotechnology, leveraging our knowledge, capabilities and footprint to develop innovative solutions for the industry.

icon Gdańsk

Our Gdansk site includes mammalian and microbial R&D and manufacturing facilities for mid-scale production including drug product and fill finish.

icon Warsaw

Our Warsaw site is one of the largest biologics manufacturing sites in Europe, with capabilities for preclinical, clinical and commercial supply to EU and US standards.

icon Utrecht

Our Utrecht site is one of innovation and leads the discovery, optimization and development of novel biologics and biosimilars as well as being home to our industry leading cell line development platform.

Our sites

With state-of-the-art facilities across Europe, Polpharma Biologics is at the forefront of the next wave in biotechnology, leveraging our knowledge, capabilities and footprint to develop innovative solutions for the industry.

  • Gdańsk
  • Warsaw
  • Utrecht
  • Our Gdansk site includes mammalian and microbial R&D and manufacturing facilities for mid-scale production including drug product and fill finish.

  • Our Warsaw site is one of the largest biologics manufacturing sites in Europe, with capabilities for preclinical, clinical and commercial supply to EU and US standards.

  • Our Utrecht site is one of innovation and leads the discovery, optimization and development of novel biologics and biosimilars as well as being home to our industry leading cell line development platform.

Our team

At Polpharma Biologics, our commitment to excellence begins at the top. With decades of combined experience in the development, manufacture and commercialization of biopharmaceuticals. Our international management team brings both knowledge and passion to every project.

"It is here that new molecules, active substances and drugs for the largest companies in the world are created"

Next
Jerzy Starak

Chairman, Polpharma Biologics Group

“We care about delivering on our commitments”

Next
Hannes Teissl

Vice Chairman, Polpharma Biologics Group

“We are passionate about getting safe and effective medicines to patients”

Next
Dr Joerg Windisch

President & CEO, Polpharma Biologics Group

"We care about delivering on our commitments"

Next
Jan Krzewiński

President, Polpharma Biologics Gdańsk

“We work with dedication and find innovative solutions”

Next
Frederic Papp

President, Polpharma Biologics Warsaw

Join our team

Whether it’s helping our partners accelerate their programs, developing biosimilars to improve patients access or discovering new and innovative medicines to add to our portfolio, all our staff are motivated by the same passion, getting safe and effective medicines to patients. Join us today.

>700

employees

>2 billion zł

invested in Polpharma Biologics

Let’s collaborate and create quality biologics together.

Get in touch for more information.